Welcure Drugs & Pharmaceuticals Ltd — Important, 25-09-2025: Company Update

Welcure Drugs & Pharmaceuticals Ltd. has announced a board meeting to deliberate a Letter of Intent from Telexcell Trade PTE LTD, Singapore, for a proposed acquisition of up to a 25% equity stake at an indicative price of ₹20 per share, a substantial premium. This meeting, initially scheduled earlier, was postponed due to director unavailability and rescheduled. The agenda includes initiating comprehensive due diligence, authorizing negotiations for definitive agreements, exploring shareholder approval mechanisms, and discussing strategic growth opportunities in global pharmaceutical and chemical exports by leveraging Telexcell’s network.